JANUVIA Side Effects

6981115-0 | Agranulocytosis
on Sep 03, 2010 Female patient from JAPAN , 86 years of age, weighting 99.21 lb, was diagnosed with type 2 diabetes mellitus, hypertension, reflux oesophagitis, osteoporosis (What is osteoporosis?), insomnia, organising pneumonia, prophylaxis, psychosomatic disease and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis. Januvia dosage: . During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ), PARIET (View Pariet Review and Pariet Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), AMOBAN (View Amoban Review and Amoban Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BACTRAMIN (View Bactramin Review and Bactramin Label ), ISCOTIN (View Iscotin Review and Iscotin Label ), DEPAS (View Depas Review and Depas Label ). Patient was hospitalized.

6981106-X | Hypoglycaemia, Loss Of Consciousness
Patient was taking Januvia (View Usage). Patient had the following side effects: hypoglycaemia, loss of consciousness on Sep 10, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), GLUCOVANCE (View Glucovance Review and Glucovance Label ), PRANDIN (View Prandin Review and Prandin Label ). Patient was hospitalized.

6981105-8 | Atrial Flutter, Atrial Tachycardia
Adverse event was reported on Sep 08, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with blood glucose abnormal, blood pressure abnormal and. Location: JAPAN , 74 years of age, After Januvia was administered, patient had the following side effects: atrial flutter, atrial tachycardia. During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), TENORMIN (View Tenormin Review and Tenormin Label ).

6981101-0 | Cerebrovascular Accident
on Sep 01, 2010 Male patient from CANADA , 46 years of age, was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Januvia dosage: .


6981099-5 | Haematuria, Prothrombin Time Prolonged
on Sep 07, 2010 Male patient from UNITED STATES , 86 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: haematuria, prothrombin time prolonged. Januvia dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), LASIX (View Lasix Review and Lasix Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized and became disabled.

6981095-8 | Cytolytic Hepatitis, Gait Disturbance, Pancreatic Insufficiency, Pancreatitis Necrotising
Patient was taking Januvia (View Usage). After Januvia was administered, patient had the following side effects: cytolytic hepatitis, gait disturbance, pancreatic insufficiency, pancreatitis necrotising on Sep 02, 2010 from FRANCE Additional patient health information: Female patient , 81 years of age, weighting 134.5 lb, was diagnosed with type 2 diabetes mellitus, hypertension, osteoarthritis (What is osteoarthritis?), venous insufficiency, diarrhoea, eye infection (What is eye infection?) and. Januvia dosage: . During the same period patient was treated with URAPIDIL (View Urapidil Review and Urapidil Label ), PERINDOPRIL ARGININE (View Perindopril Arginine Review and Perindopril Arginine Label ), CHONDROITIN SULFATE SODIUM (View Chondroitin Sulfate Sodium Review and Chondroitin Sulfate Sodium Label ), DIOSMIN (View Diosmin Review and Diosmin Label ), LOPERAMIDE HYDROCHLORIDE (View Loperamide Hydrochloride Review and Loperamide Hydrochloride Label ), CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ). Patient was hospitalized.

6981093-4 | Vascular Purpura
Adverse event was reported on Sep 07, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 81 years of age, Patient experienced the following unwanted or unexpected effects: vascular purpura. Patient was hospitalized.

6978961-6 | Hyponatraemia
on Sep 03, 2010 Female patient from JAPAN , 75 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, myocardial ischaemia, hypertension, hypovitaminosis, peripheral circulatory failure and was treated with Januvia (View Usage). Patient had the following side effects: hyponatraemia. Januvia dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BLOPRESS (View Blopress Review and Blopress Label ), AMARYL (View Amaryl Review and Amaryl Label ), VITANEURIN (FURSULTIAMINE (+) HYDROXOCOBALAMIN ACETATE (+) PYRIDOXAL P (View Vitaneurin (fursultiamine (+) Hydroxocobalamin Acetate (+) Pyridoxal P Review and Vitaneurin (fursultiamine (+) Hydroxocobalamin Acetate (+) Pyridoxal P Label ), HICEE (View Hicee Review and Hicee Label ), JUVELA (View Juvela Review and Juvela Label ), HERBESSER R (View Herbesser R Review and Herbesser R Label ), ARTIST (View Artist Review and Artist Label ). Patient was hospitalized.

6978957-4 | Pyrexia
on Sep 07, 2010 Male patient from JAPAN , 57 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: pyrexia. Januvia dosage: . During the same period patient was treated with HERBESSER (View Herbesser Review and Herbesser Label ), ACTOS (View Actos Review and Actos Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), AMARYL (View Amaryl Review and Amaryl Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

6978941-0 | Coronary Artery Disease, Vocal Cord Thickening
Patient was taking Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?), vocal cord thickening on Sep 09, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 154.3 lb, was diagnosed with diabetes mellitus and. Januvia dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized and became disabled.

6977104-2 | Joint Swelling, Pyrexia
Adverse event was reported on Sep 02, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, dyslipidaemia and. Location: JAPAN , 78 years of age, weighting 149.9 lb, Patient had the following side effects: joint swelling, pyrexia. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), SEIBULE (View Seibule Review and Seibule Label ), GLUFAST (View Glufast Review and Glufast Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), LIVALO (View Livalo Review and Livalo Label ).

6977098-X | C-reactive Protein Increased, Pyrexia
on Sep 01, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with diabetes mellitus, cerebral infarction, hypertension, dyslipidaemia and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: c-reactive protein increased, pyrexia. Januvia dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), PLETAL (View Pletal Review and Pletal Label ), MICARDIS (View Micardis Review and Micardis Label ), MEVAN (View Mevan Review and Mevan Label ). Patient was hospitalized.

6977082-6 | Cardiac Failure, Renal Failure
on Aug 31, 2010 Female patient from JAPAN , 58 years of age, was diagnosed with type 2 diabetes mellitus, lumbar spinal stenosis and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, renal failure. Januvia dosage: . During the same period patient was treated with LEXOTAN (View Lexotan Review and Lexotan Label ), LOXONIN (View Loxonin Review and Loxonin Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), AMARYL (View Amaryl Review and Amaryl Label ), BENZALIN (View Benzalin Review and Benzalin Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6974556-9 | Pancreatitis
Patient was taking Januvia (View Usage). Patient had the following side effects: pancreatitis on Sep 09, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 231.0 lb, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: 100 Mg Daily Po. Patient was hospitalized.

6974501-6 | Herpes Zoster
Adverse event was reported on Sep 02, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, hypertension, hyperlipidaemia, atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , weighting 183.0 lb, After Januvia was administered, patient had the following side effects: herpes zoster. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LIPITOR (View Lipitor Review and Lipitor Label ), DIOVAN (View Diovan Review and Diovan Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), WARFARIN (Divided Dosage Frequency) (View Warfarin Review and Warfarin Label ), FASTIC (View Fastic Review and Fastic Label ).

6974500-4 | Hypoglycaemia
on Sep 02, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Januvia dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), AMARYL (View Amaryl Review and Amaryl Label ).

6974495-3 | Vascular Purpura
on Sep 07, 2010 Male patient from FRANCE , 81 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: vascular purpura. Januvia dosage: . Patient was hospitalized.

6974493-X | Altered State Of Consciousness, Gastrointestinal Haemorrhage
Patient was taking Januvia (View Usage). After Januvia was administered, patient had the following side effects: altered state of consciousness, gastrointestinal haemorrhage on Sep 01, 2010 from JAPAN Additional patient health information: Male patient , 85 years of age, . Januvia dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), OLMETEC (View Olmetec Review and Olmetec Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), WARFARIN POTASSIUM (View Warfarin Potassium Review and Warfarin Potassium Label ), PEPCID (View Pepcid Review and Pepcid Label ), DIART (View Diart Review and Diart Label ), SALOBEL (View Salobel Review and Salobel Label ). Patient was hospitalized.

6973443-X | Hepatitis
Adverse event was reported on Sep 01, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, diabetic nephropathy and. Location: JAPAN , 61 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ). Patient was hospitalized.

6973438-6 | Hepatitis
on Sep 01, 2010 Female patient from JAPAN , 61 years of age, weighting 132.3 lb, was diagnosed with diabetes mellitus, diabetic nephropathy and was treated with Januvia (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Januvia dosage: . During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ). Patient was hospitalized.

6973434-9 | Cerebral Infarction
on Aug 27, 2010 Male patient from JAPAN , 60 years of age, was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: cerebral infarction. Januvia dosage: . Patient was hospitalized.

6971156-1 | Hypoglycaemia, Nephrotic Syndrome
Patient was taking Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, nephrotic syndrome on Sep 01, 2010 from JAPAN Additional patient health information: Male patient , 85 years of age, was diagnosed with diabetes mellitus and. Januvia dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6971147-0 | Tubulointerstitial Nephritis
Adverse event was reported on Aug 30, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, hypertension, hyperlipidaemia and. Location: JAPAN , 69 years of age, Patient had the following side effects: tubulointerstitial nephritis. During the same period patient was treated with AVAPRO (View Avapro Review and Avapro Label ), LIPIDIL (View Lipidil Review and Lipidil Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ACTOS (View Actos Review and Actos Label ).

6971138-X | Macular Oedema
on Sep 01, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with diabetes mellitus, gastritis, insomnia and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: macular oedema. Januvia dosage: Divided Dose Frequency U. During the same period patient was treated with GLIMICRON (Divided Dose Frequency U) (View Glimicron Review and Glimicron Label ), TAKEPRON (Divided Dose Frequency U) (View Takepron Review and Takepron Label ), AMOBAN (Divided Dose Frequency U) (View Amoban Review and Amoban Label ), KARY UNI (View Kary Uni Review and Kary Uni Label ).

6968750-0 | Hyperglycaemia
on Aug 24, 2010 Male patient from JAPAN , 55 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia. Januvia dosage: . During the same period patient was treated with AVAPRO (View Avapro Review and Avapro Label ).

6968741-X | Alanine Aminotransferase Increased, Arthralgia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Chronic Hepatitis, Gamma-glutamyltransferase Increased, Hepatic Fibrosis, Jaundice
Patient was taking Januvia (View Usage). Patient had the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chronic hepatitis, gamma-glutamyltransferase increased, hepatic fibrosis, jaundice (What is jaundice?) on Aug 31, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6968728-7 | Interstitial Lung Disease
Adverse event was reported on Aug 31, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 60 years of age, After Januvia was administered, patient had the following side effects: interstitial lung disease.

6968719-6 | Adverse Event, Dizziness, Dyspnoea, Loss Of Consciousness
on Aug 31, 2010 Female patient from UNITED STATES , 76 years of age, was diagnosed with diabetes mellitus and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, dizziness (What is dizziness?), dyspnoea, loss of consciousness. Januvia dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

6965762-8 | Pancreatic Carcinoma, Pancreatic Disorder
on Aug 30, 2010 Female patient from UNITED STATES , 86 years of age, weighting 143.3 lb, was diagnosed with type 2 diabetes mellitus, gastrooesophageal reflux disease, neuropathy peripheral, anxiety (What is anxiety?), hypothyroidism, platelet aggregation, blood cholesterol and was treated with Januvia (View Usage). Patient had the following side effects: pancreatic carcinoma, pancreatic disorder. Januvia dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), NEXIUM (View Nexium Review and Nexium Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TEMODAL (View Temodal Review and Temodal Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6965760-4 | Diabetes Mellitus, Pancreatitis Acute
Patient was taking Januvia (View Usage). After Januvia was administered, patient had the following side effects: diabetes mellitus, pancreatitis acute on Aug 27, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with diabetes mellitus and. Januvia dosage: . Patient was hospitalized.

6965755-0 | Pyrexia
Adverse event was reported on Aug 27, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 57 years of age, Patient experienced the following unwanted or unexpected effects: pyrexia. During the same period patient was treated with HERBESSER (View Herbesser Review and Herbesser Label ), ACTOS (View Actos Review and Actos Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), AMARYL (View Amaryl Review and Amaryl Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

6965731-8 | Polyarthritis
on Aug 31, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: polyarthritis. Januvia dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METFORMIN (View Metformin Review and Metformin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), COZAAR (View Cozaar Review and Cozaar Label ), PEPCID (View Pepcid Review and Pepcid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized and became disabled.

6963894-1 | Fall, Femoral Neck Fracture, Post Procedural Complication
on Aug 27, 2010 Female patient from FRANCE , 92 years of age, weighting 94.80 lb, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: fall (What is fall?), femoral neck fracture, post procedural complication. Januvia dosage: . Patient was hospitalized.

6963269-5 | Abdominal Discomfort, Cardiac Disorder, Peripheral Vascular Disorder
Patient was taking Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, cardiac disorder, peripheral vascular disorder on Aug 27, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with diabetes mellitus and. Januvia dosage: . Patient was hospitalized.

6963267-1 | Cardiac Failure, Renal Failure
Adverse event was reported on Aug 25, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, lumbar spinal stenosis and. Location: JAPAN , 58 years of age, Patient had the following side effects: cardiac failure, renal failure. During the same period patient was treated with LEXOTAN (View Lexotan Review and Lexotan Label ), LOXONIN (View Loxonin Review and Loxonin Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), MELBIN (View Melbin Review and Melbin Label ), AMARYL (View Amaryl Review and Amaryl Label ), BENZALIN (View Benzalin Review and Benzalin Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6963262-2 | Hyperthermia
on Aug 26, 2010 Male patient from JAPAN , 61 years of age, was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: hyperthermia. Januvia dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6963252-X | Hyponatraemia
on Aug 26, 2010 Female patient from JAPAN , 75 years of age, was diagnosed with diabetes mellitus, myocardial ischaemia, hypertension and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Januvia dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BLOPRESS (View Blopress Review and Blopress Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6961780-4 | Dyspnoea, Hyperhidrosis, Paraesthesia Oral
Patient was taking Januvia (View Usage). Patient had the following side effects: dyspnoea, hyperhidrosis, paraesthesia oral on Aug 24, 2010 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 61 years of age, weighting 130.1 lb, was diagnosed with diabetes mellitus, cardiovascular event prophylaxis, hypertension and. Januvia dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), AMLODIPINE BESYLATE AND VALSARTAN (View Amlodipine Besylate And Valsartan Review and Amlodipine Besylate And Valsartan Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

6961047-4 | Erythema Multiforme, Insomnia
Adverse event was reported on Aug 24, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, hyperlipidaemia, hypertension, hypothyroidism and. Location: JAPAN , 67 years of age, weighting 132.3 lb, After Januvia was administered, patient had the following side effects: erythema multiforme, insomnia. During the same period patient was treated with GLYCORAN (View Glycoran Review and Glycoran Label ), BASEN (View Basen Review and Basen Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), CRESTOR (View Crestor Review and Crestor Label ), NORVASC (View Norvasc Review and Norvasc Label ), MICARDIS (View Micardis Review and Micardis Label ), THYRADIN (View Thyradin Review and Thyradin Label ).

6961029-2 | Haemolytic Anaemia
on Aug 23, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia. Januvia dosage: . During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ), LIVALO (View Livalo Review and Livalo Label ), MELBIN (View Melbin Review and Melbin Label ). Patient was hospitalized.

6961026-7 | Cardiac Arrest
on Aug 25, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with diabetes mellitus, back pain (What is back pain?), gastritis, dyslipidaemia, schizophrenia and was treated with Januvia (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Januvia dosage: 1 Mg And Eumunae 2 Mg After Supper. During the same period patient was treated with LOXONIN (View Loxonin Review and Loxonin Label ), TAKEPRON (View Takepron Review and Takepron Label ), ADOFEED (View Adofeed Review and Adofeed Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), EPADEL (View Epadel Review and Epadel Label ), MELBIN (View Melbin Review and Melbin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6961021-8 | Aphonia
Patient was taking Januvia (View Usage). After Januvia was administered, patient had the following side effects: aphonia on Aug 26, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 154.3 lb, was diagnosed with diabetes mellitus and. Januvia dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

6961020-6 | Gastrointestinal Erosion, Gastrointestinal Oedema
Adverse event was reported on Aug 26, 2010 by a Female patient taking Januvia (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: JAPAN , 77 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal erosion, gastrointestinal oedema. Patient was hospitalized.

6959602-0 | Asthenia, Atrial Fibrillation, Autonomic Nervous System Imbalance, Blood Creatine Increased, Blood Pressure Fluctuation, Blood Urea Increased, Condition Aggravated, Decreased Appetite, Diabetic Neuropathy
on Aug 18, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). Patient had the following side effects: asthenia, atrial fibrillation (What is atrial fibrillation?), autonomic nervous system imbalance, blood creatine increased, blood pressure fluctuation, blood urea increased, condition aggravated, decreased appetite, diabetic neuropathy. Januvia dosage: 100 Mg/daily Po; 50 Mg/daily; 50 Mg/daily; 1 Tab/daily. During the same period patient was treated with ALMATOL (View Almatol Review and Almatol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BLOPRESS (View Blopress Review and Blopress Label ), CIBENOL (View Cibenol Review and Cibenol Label ). Patient was hospitalized.

6959397-0 | Pancreatic Disorder
on Aug 26, 2010 Female patient from UNITED STATES , 87 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: pancreatic disorder. Januvia dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), NEXIUM (View Nexium Review and Nexium Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TEMODAL (View Temodal Review and Temodal Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6958554-7 | Hyponatraemia
Patient was taking Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia on Aug 23, 2010 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with diabetes mellitus, myocardial ischaemia, hypertension and. Januvia dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BLOPRESS (View Blopress Review and Blopress Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6958538-9 | Hyperglycaemia
Adverse event was reported on Aug 20, 2010 by a Male patient taking Januvia (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, dyslipidaemia and. Location: JAPAN , 55 years of age, Patient had the following side effects: hyperglycaemia. During the same period patient was treated with AVAPRO (View Avapro Review and Avapro Label ).

6958536-5 | Agranulocytosis
on Aug 25, 2010 Female patient from JAPAN , 86 years of age, weighting 99.21 lb, was diagnosed with type 2 diabetes mellitus, hypertension, ill-defined disorder and was treated with Januvia (View Usage). After Januvia was administered, patient had the following side effects: agranulocytosis. Januvia dosage: . During the same period patient was treated with BLOPRESS (View Blopress Review and Blopress Label ), PARIET (View Pariet Review and Pariet Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), AMOBAN (View Amoban Review and Amoban Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), BACTRAMIN (View Bactramin Review and Bactramin Label ), ISCOTIN (View Iscotin Review and Iscotin Label ), DEPAS (View Depas Review and Depas Label ). Patient was hospitalized.

6956862-7 | Erythema Multiforme, Insomnia
on Aug 24, 2010 Female patient from JAPAN , 67 years of age, weighting 132.3 lb, was diagnosed with diabetes mellitus, hyperlipidaemia, hypertension, hypothyroidism and was treated with Januvia (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, insomnia. Januvia dosage: . During the same period patient was treated with GLYCORAN (View Glycoran Review and Glycoran Label ), BASEN (View Basen Review and Basen Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), CRESTOR (View Crestor Review and Crestor Label ), NORVASC (View Norvasc Review and Norvasc Label ), MICARDIS (View Micardis Review and Micardis Label ), THYRADIN (View Thyradin Review and Thyradin Label ).

6955957-1 | Hypoglycaemia
Patient was taking Januvia (View Usage). Patient had the following side effects: hypoglycaemia on Aug 20, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with type 2 diabetes mellitus and. Januvia dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), AMARYL (View Amaryl Review and Amaryl Label ).